文献速递肿瘤 PET/CT骨显像与常规 SPECT

全身正电子发射断层显像/计算机体层摄影三个肌肉骨骼部位异常可高敏感性和特异性诊断风湿性多肌痛

Abnormalities at three musculoskeletal sites on whole-body positron emission tomography/computed tomography can diagnose polymyalgia rheumatica with high sensitivity and specificity.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2020-02-23

本研究前瞻性纳入33例新诊断风湿性多肌痛(PMR)患者,按年龄和性别与132例对照匹配,评估全身18F-FDG PET/CT在21个肌肉骨骼部位的异常摄取。单个部位不足以诊断,而坐骨结节旁摄取≥2且肩关节周围或棘间滑囊异常的组合算法诊断PMR的敏感性为90.9%、特异性为92.4%。

要点

  • 坐骨结节旁18F-FDG摄取≥2合并肩关节周围或棘间滑囊异常诊断PMR敏感性90.9%、特异性92.4%。
  • 单个肌肉骨骼部位异常不足以诊断PMR。
  • PMR组中位C反应蛋白49 mg/L、红细胞沉降率41.5 mm/h。

核心结论

  • 全身PET/CT上坐骨结节旁异常18F-FDG摄取合并肩关节周围或棘间滑囊表现对PMR诊断具有高敏感性和特异性。

研究设计与样本

  • 前瞻性招募未使用类固醇的新诊断PMR患者(符合2012 EULAR/ACR分类标准)接受全身18F-FDG PET/CT,每例按年龄和性别与4例PET/CT对照匹配。
  • 对病例和对照的21个肌肉骨骼部位异常18F-FDG摄取进行定性和半定量评分(最大标准化摄取值SUVmax),并采用分类与回归树(CART)方法开发诊断算法。

主要发现

  • 33例病例符合纳入标准并与132例对照匹配,病例平均年龄68.6±7.4岁 vs 对照68.2±7.3岁,男性占54.5%。
  • PMR组中位C反应蛋白49 mg/L(32-65)、红细胞沉降率41.5 mm/h(24.6-64.4)。
  • 对照组PET/CT主要检查指征为恶性肿瘤(63.6%)。
  • 单个肌肉骨骼部位不足以用于诊断目的。
  • 新算法(坐骨结节旁18F-FDG摄取≥2合并肩关节周围或棘间滑囊异常)诊断PMR的敏感性为90.9%、特异性为92.4%。

关键数值与推荐

  • 诊断算法:坐骨结节旁18F-FDG摄取≥2,合并肩关节周围或棘间滑囊异常,敏感性90.9%、特异性92.4%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To evaluate the sensitivity and specificity of PET/CT findings in PMR and generate a diagnostic algorithm utilizing a minimum number of musculoskeletal sites. METHODS: Steroid-naïve patients with newly diagnosed PMR (2012 EULAR/ACR classification criteria) were prospectively recruited to undergo whole-body 18F-FDG PET/CT. Each PMR case was age- and sex-matched to four PET/CT controls. Control scan indication, diagnosis and medical history were extracted from the clinical record. Qualitative and semi-quantitative scoring (maximum standardized uptake value [SUVmax]) of abnormal 18F-FDG uptake at 21 musculoskeletal sites was undertaken for cases and controls. Results informed the development of a novel PET/CT diagnostic algorithm using a classification and regression trees (CART) method. RESULTS: Thirty-three cases met the inclusion criteria and were matched to 132 controls. Mean age was 68.6 ± 7.4 years for cases compared with 68.2 ± 7.3 for controls, and 54.5% were male. Median CRP was 49 mg/L (32-65) and ESR 41.5 mm/h (24.6-64.4) in the PMR group. The predominant control indication for PET/CT was malignancy (63.6%). Individual musculoskeletal sites proved insufficient for diagnostic purposes. A novel algorithm comprising 18F-FDG uptake ≥ 2 adjacent to the ischial tuberosities in combination with either abnormalities at the peri-articular shoulder or interspinous bursa achieved a sensitivity of 90.9% and specificity of 92.4% for diagnosing PMR. CONCLUSIONS: The presence of abnormal 18F-FDG uptake adjacent to the ischial tuberosities together with findings at the peri-articular shoulder or interspinous bursa on whole-body PET/CT is highly sensitive and specific for a diagnosis of PMR. TRIAL REGISTRATION: Clinical Trial Registration: Australian New Zealand Clinical Trials Registry, http://www.anzctr.org.au , ACTRN1261400696695.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Owen CE, Poon AMT, Yang V, et al. Abnormalities at three musculoskeletal sites on whole-body positron emission tomography/computed tomography can diagnose polymyalgia rheumatica with high sensitivity and specificity. Eur J Nucl Med Mol Imaging. 2020. PMID: 32090280. doi:10.1007/s00259-020-04731-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。